AS
Amrik Singh
About Amrik Singh
Data last updated:
Amrik Singh is a Whole-Time Director at Ultra Chiron Pharmaceuticals Pvt Ltd (since 2014). The company operates in Pharma. Ultra Chiron Pharmaceuticals Pvt Ltd reported revenue of ₹6.09 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Ultra Chiron Pharmaceuticals Pvt Ltd U24231CH1993PTC013535 | Whole-Time Director | 23 Dec 2014 | 1993 | ₹6.09 Cr (FY 2025) | Active |
Board colleagues of Amrik Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashok Kumar Mishra | 10982749 | Ultra Chiron Pharmaceuticals Pvt Ltd | Additional Director |
| Mitesh Kumar | 02920296 | Ultra Chiron Pharmaceuticals Pvt Ltd | Director |
| Rajesh Biswanath Shrivastava | 00155198 | Ultra Chiron Pharmaceuticals Pvt Ltd | Director |
| Sadhu Singh | 02899199 | Ultra Chiron Pharmaceuticals Pvt Ltd | Director |
| Sanjeev Kumar | 01154896 | Ultra Chiron Pharmaceuticals Pvt Ltd | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amrik Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amrik Singh
Amrik Singh currently holds 1 directorship: Ultra Chiron Pharmaceuticals Pvt Ltd (Whole-Time Director, since 23 Dec 2014, revenue ₹6.09 Cr (FY 2025)).
Amrik Singh was first appointed on 23 Dec 2014 as Whole-Time Director at Ultra Chiron Pharmaceuticals Pvt Ltd.
The current boards of Amrik Singh's companies include Ashok Kumar Mishra (Ultra Chiron Pharmaceuticals Pvt Ltd), Mitesh Kumar (Ultra Chiron Pharmaceuticals Pvt Ltd), Rajesh Biswanath Shrivastava (Ultra Chiron Pharmaceuticals Pvt Ltd), Sadhu Singh (Ultra Chiron Pharmaceuticals Pvt Ltd), Sanjeev Kumar (Ultra Chiron Pharmaceuticals Pvt Ltd).